论文部分内容阅读
并购似乎正成为全球医药巨头们的主旋律。今年1月,全球制药大鳄辉瑞以680亿美元并购惠氏;3月,默沙东公司以411亿美元的价格收购先灵葆雅—巨头间的合并不但改变了全球
M & A seems to be becoming the main theme of the global pharmaceutical giants. January of this year, the global pharmaceutical predators Pfizer 680 million acquisition of Wyeth; March, Merck Smith Company to $ 41.1 billion acquisition of Schering-Plow - the merger between giants not only changed the world